WASHINGTON DC (April 9, 2020) — The US Food and Drug Administration has issued a warning letter to a seller that markets fraudulent and dangerous chlorine-dioxide products known as “Miracle Mineral Solution” for prevention and treatment of “Novel Coronavirus Disease 2019” (COVID-19).

WASHINGTON DC (April 3, 2020) — The US Food and Drug Administration continues to play a critical role in accelerating medical countermeasures to treat and prevent COVID-19. As part of the response to this pandemic, the agency is taking the lead on a national effort to facilitate the development of, and access to, two investigational therapies derived from human blood.

WASHINGTON DC (April 2, 2020) — On March 1, The US Food and Drug Administration announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.

WASHINGTON DC (March 30, 2020) — The US Food and Drug Administration has been providing unprecedented flexibility to labs and manufacturers to develop and offer COVID-19 tests across the US. The FDA’s regulations have not hindered or been a roadblock to the rollout of tests during this pandemic.

WASHINGTON DC (March 24, 2020) — Today is a historic day and a landmark moment for patients with diabetes and other serious medical conditions, as insulin and certain other biologic drugs transition to a different regulatory pathway. This regulatory transition, mandated by Congress and implemented by the FDA, is incredibly important for patients.

DALLAS, TEXAS (August 12, 2019) — The US Food and Drug Administration is warning consumers not to purchase or drink a product sold online as a medical treatment due to a recent rise in reported health issues.

DALLAS, TEXAS (August 9, 2019) — The US Food and Drug Administration issued warning letters notifying four companies that 44 flavored e-liquid and hookah tobacco products do not have the required marketing authorization, and thus cannot be legally sold in the United States.

DALLAS, TEXAS (July 31, 2019) — The US Department of Health and Human Services (HHS) announced today that HHS and the US Food and Drug Administration (FDA) are publishing a Safe Importation Action Plan - PDF* that outlines two potential pathways that would lay the foundation for the safe importation of certain drugs originally intended for foreign markets.

WASHINGTON DC (July 2, 2019) — “Fish and shellfish are an important part of a well-rounded diet. However, we know many consumers worry about mercury in fish and even choose to limit or avoid fish because of this concern. In fact, we have seen that women in the US who are pregnant are consuming far less than the recommended amount of seafood,” said Susan Mayne PhD, director of the Federal Drug Administration's [FDA] Center for Food Safety and Applied Nutrition.

Pages